YAP1 and neuroblastoma: In conclusion, we identify a strong prognostic impact of neuroendocrine-lineage transcriptional profiles in neuroblastoma, and suggest that the evaluation of NOTCH1, INSM1, YAP1, and NEUROD1 might help to further characterize the risk of relapse in neuroblastoma patients.